Skip to main content
Log in

Analysis of cannabinoids in oral fluid by liquid chromatography–tandem mass spectrometry

  • Short Communication
  • Published:
Forensic Toxicology Aims and scope Submit manuscript

Abstract

A sensitive method was developed for quantifying a wide range of cannabinoids in oral fluid (OF) by liquid chromatography–tandem mass spectrometry (LC–MS/MS). These cannabinoids include ∆9-tetrahydrocannabinol (THC), 11-hydroxy-∆9-tetrahydrocannabinol (11-OH-THC), 11-nor-9-carboxy-∆9-tetrahydrocannabinol (THCCOOH), cannabinol (CBN), cannabidiol (CBD), ∆9-tetrahydrocannabinolic acid A (THC-A), 11-nor-9-carboxy-∆9-tetrahydrocannabinol glucuronide (THCCOOH-gluc), and ∆9-tetrahydrocannabinol glucuronide (THC-gluc). Samples were collected using a Quantisal™ device. The advantages of performing a liquid–liquid extraction (LLE) of KCl-saturated OF using heptane/ethyl acetate versus a solid-phase extraction (SPE) using HLB copolymer columns were determined. Chromatographic separation was achieved in 11.5 min on a Kinetex™ column packed with 2.6-μm core–shell particles. Both positive (THC, 11-OH-THC, CBN, and CBD) and negative (THCCOOH, THC-gluc, THCCOOH-gluc, and THC-A) electrospray ionization modes were employed with multiple reaction monitoring using a high-end AB Sciex API 5000™ triple quadrupole LC–MS/MS system. Unlike SPE, LLE failed to extract THC-gluc and THCCOOH-gluc. However, the LLE method was more sensitive for the detection of THCCOOH than the SPE method, wherein the limit of detection (LOD) and limit of quantification (LOQ) decreased from 100 to 50 pg/ml and from 500 to 80 pg/ml, respectively. The two extraction methods were successfully applied to OF samples collected from volunteers before and after they smoked a homemade cannabis joint. High levels of THC were measured soon after smoking, in addition to significant amounts of THC-A. Other cannabinoids were found in low concentrations. Glucuronide conjugate levels were lower than the method’s LOD for most samples. Incubation studies suggest that glucuronides could be enzymatically degraded by glucuronidase prior to OF collection.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Kelly E, Darke S, Ross J (2004) A review of drug use and driving: epidemiology, impairment, risk factors and risk perceptions. Drug Alcohol Rev 23(3):319–344. doi:10.1080/09595230412331289482

    Article  PubMed  Google Scholar 

  2. Choo RE, Huestis MA (2004) Oral fluid as a diagnostic tool. Clin Chem Lab Med 42(11):1273–1287. doi:10.1515/CCLM.2004.248

    Article  PubMed  CAS  Google Scholar 

  3. Molnar A, Lewis J, Doble P, Hansen G, Prolov T, Fu S (2011) A rapid and sensitive method for the identification of delta-9-tetrahydrocannabinol in oral fluid by liquid chromatography–tandem mass spectrometry. Forensic Sci Int. doi:10.1016/j.forsciint.2011.01.045

    PubMed  Google Scholar 

  4. Moore C, Rana S, Coulter C, Day D, Vincent M, Soares J (2007) Detection of conjugated 11-nor-Delta9-tetrahydrocannabinol-9-carboxylic acid in oral fluid. J Anal Toxicol 31(4):187–194

    PubMed  CAS  Google Scholar 

  5. Lee D, Milman G, Barnes AJ, Goodwin RS, Hirvonen J, Huestis MA (2011) Oral fluid cannabinoids in chronic, daily Cannabis smokers during sustained, monitored abstinence. Clin Chem 57(8):1127–1136. doi:10.1373/clinchem.2011.164822

    Article  PubMed  CAS  Google Scholar 

  6. Milman G, Barnes AJ, Schwope DM, Schwilke EW, Darwin WD, Goodwin RS, Kelly DL, Gorelick DA, Huestis MA (2010) Disposition of cannabinoids in oral fluid after controlled around-the-clock oral THC administration. Clin Chem 56(8):1261–1269. doi:10.1373/clinchem.2009.141853

    Article  PubMed  CAS  Google Scholar 

  7. Milman G, Schwope DM, Schwilke EW, Darwin WD, Kelly DL, Goodwin RS, Gorelick DA, Huestis MA (2011) Oral fluid and plasma cannabinoid ratios after around-the-clock controlled oral Delta(9)-tetrahydrocannabinol administration. Clin Chem 57(11):1597–1606. doi:10.1373/clinchem.2011.169490

    Article  PubMed  CAS  Google Scholar 

  8. Moore C, Rana S, Coulter C (2007) Simultaneous identification of 2-carboxy-tetrahydrocannabinol, tetrahydrocannabinol, cannabinol and cannabidiol in oral fluid. J Chromatogr B Analyt Technol Biomed Life Sci 852(1–2):459–464. doi:10.1016/j.jchromb.2007.02.016

    PubMed  CAS  Google Scholar 

  9. Coles R, Clements TT, Nelson GJ, McMillin GA, Urry FM (2005) Simultaneous analysis of the Delta9-THC metabolites 11-nor-9-carboxy-Delta9-THC and 11-hydroxy-Delta9-THC in meconium by GC–MS. J Anal Toxicol 29(6):522–527

    PubMed  CAS  Google Scholar 

  10. ElSohly MA, Feng S (1998) Delta 9-THC metabolites in meconium: identification of 11-OH-delta 9-THC, 8 beta, 11-diOH-delta 9-THC, and 11-nor-delta 9-THC-9-COOH as major metabolites of delta 9-THC. J Anal Toxicol 22(4):329–335

    PubMed  CAS  Google Scholar 

  11. Fabritius M, Staub C, Mangin P, Giroud C (2012) Distribution of free and conjugated cannabinoids in human bile samples. Forensic Sci Int. http://dx.doi.org/10.1016/j.forsciint.2012.08.013

  12. Feng S, ElSohly MA, Salamone S, Salem MY (2000) Simultaneous analysis of delta9-THC and its major metabolites in urine, plasma, and meconium by GC–MS using an immunoaffinity extraction procedure. J Anal Toxicol 24(6):395–402

    PubMed  CAS  Google Scholar 

  13. Gronewold A, Skopp G (2011) A preliminary investigation on the distribution of cannabinoids in man. Forensic Sci Int 210(1–3):e7–e11. doi:10.1016/j.forsciint.2011.04.010

    Article  PubMed  CAS  Google Scholar 

  14. Lin DL, Lin RL (2005) Distribution of 11-nor-9-carboxy-Delta9-tetrahydrocannabinol in traffic fatality cases. J Anal Toxicol 29(1):58–61

    PubMed  CAS  Google Scholar 

  15. Marchei E, Pellegrini M, Pacifici R, Palmi I, Lozano J, Garcia-Algar O, Pichini S (2006) Quantification of Delta9-tetrahydrocannabinol and its major metabolites in meconium by gas chromatographic-mass spectrometric assay: assay validation and preliminary results of the “meconium project”. Ther Drug Monit 28(5):700–706. doi:10.1097/01.ftd.0000245380.95186.13

  16. Moore C, Lewis D, Becker J, Leikin J (1996) The determination of 11-nor-delta 9-tetrahydrocannabinol-9-carboxylic acid (THCCOOH) in meconium. J Anal Toxicol 20(1):50–51

    PubMed  CAS  Google Scholar 

  17. Papoutsis I, Nikolaou P, Dona A, Pistos C, Stefanidou M, Spiliopoulou C, Athanaselis S (2012) A validated GC–MS method for the determination of ∆9-tetrahydrocannabinol and 11-nor-∆9-tetrahydrocannabinol-9-carboxylic acid in bile samples. Forensic Toxicol 30(1):51–58. doi:10.1007/s11419-011-0126-1

    Google Scholar 

  18. Badawi N, Simonsen KW, Steentoft A, Bernhoft IM, Linnet K (2009) Simultaneous screening and quantification of 29 drugs of abuse in oral fluid by solid-phase extraction and ultraperformance LC–MS/MS. Clin Chem 55 (11):2004–2018. doi:10.1373/clinchem.2008.122341

    Google Scholar 

  19. Chi E, Cole J (2010) Detecting Marijuana in Saliva. Forensic Mag 7(5):17–20

    Google Scholar 

  20. Concheiro M, de Castro A, Quintela O, Cruz A, Lopez-Rivadulla M (2008) Determination of illicit and medicinal drugs and their metabolites in oral fluid and preserved oral fluid by liquid chromatography–tandem mass spectrometry. Anal Bioanal Chem 391(6):2329–2338. doi:10.1007/s00216-008-2135-4

    Article  PubMed  CAS  Google Scholar 

  21. Day D, Kuntz DJ, Feldman M, Presley L (2006) Detection of THCA in oral fluid by GC–MS–MS. J Anal Toxicol 30(9):645–650

    PubMed  CAS  Google Scholar 

  22. Laloup M, Ramirez Fernandez Mdel M, Wood M, De Boeck G, Henquet C, Maes V, Samyn N (2005) Quantitative analysis of delta9-tetrahydrocannabinol in preserved oral fluid by liquid chromatography–tandem mass spectrometry. J Chromatogr A 1082(1):15–24

  23. Niedbala RS, Kardos KW, Fritch DF, Kardos S, Fries T, Waga J, Robb J, Cone EJ (2001) Detection of marijuana use by oral fluid and urine analysis following single-dose administration of smoked and oral marijuana. J Anal Toxicol 25(5):289–303

    PubMed  CAS  Google Scholar 

  24. Oiestad EL, Johansen U, Christophersen AS (2007) Drug screening of preserved oral fluid by liquid chromatography–tandem mass spectrometry. Clin Chem 53(2):300–309. doi:10.1373/clinchem.2006.074237

    Google Scholar 

  25. Quintela O, Andrenyak DM, Hoggan AM, Crouch DJ (2007) A validated method for the detection of Delta 9-tetrahydrocannabinol and 11-nor-9-carboxy- Delta 9-tetrahydrocannabinol in oral fluid samples by liquid chromatography coupled with quadrupole-time-of-flight mass spectrometry. J Anal Toxicol 31(3):157–164

    PubMed  CAS  Google Scholar 

  26. Sergi M, Bafile E, Compagnone D, Curini R, D’Ascenzo G, Romolo FS (2009) Multiclass analysis of illicit drugs in plasma and oral fluids by LC–MS/MS. Anal Bioanal Chem 393(2):709–718. doi:10.1007/s00216-008-2456-3

    Article  PubMed  CAS  Google Scholar 

  27. Simoes SS, Ajenjo AC, Franco JM, Vieira DN, Dias MJ (2009) Liquid chromatography/tandem mass spectrometry for the qualitative and quantitative analysis of illicit drugs and medicines in preserved oral fluid. Rapid Commun Mass Spectrom 23(10):1451–1460. doi:10.1002/rcm.4020

    Article  PubMed  CAS  Google Scholar 

  28. Simonin J, Salquebre G, Cirimele V, Kintz P (2007) Screening for illicit drugs in oral fluid by LC–MS/MS. Ann Toxicol Anal 19(2):141–150

    Article  Google Scholar 

  29. Gritti F, Guiochon G (2010) Performance of columns packed with the new shell Kinetex-C18 particles in gradient elution chromatography. J Chromatogr A 1217(10):1604–1615. doi:10.1016/j.chroma.2010.01.008

    Article  PubMed  CAS  Google Scholar 

  30. Gritti F, Leonardis I, Shock D, Stevenson P, Shalliker A, Guiochon G (2010) Performance of columns packed with the new shell particles, Kinetex-C18. J Chromatogr A 1217(10):1589–1603. doi:10.1016/j.chroma.2009.12.079

    Article  PubMed  CAS  Google Scholar 

  31. Moore C, Vincent M, Rana S, Coulter C, Agrawal A, Soares J (2006) Stability of Delta(9)-tetrahydrocannabinol (THC) in oral fluid using the Quantisal collection device. Forensic Sci Int 164(2–3):126–130. doi:10.1016/j.forsciint.2005.12.011

    Article  PubMed  CAS  Google Scholar 

  32. Hubert P, Nguyen-Huu JJ, Boulanger B, Chapuzet E, Chiap P, Cohen N, Compagnon PA, Dewe W, Feinberg M, Lallier M, Laurentie M, Mercier N, Muzard G, Nivet C, Valat L, Rozet E (2007) Harmonization of strategies for the validation of quantitative analytical procedures. A SFSTP proposal—part II. J Pharm Biomed Anal 45(1):70–81. doi:10.1016/j.jpba.2007.06.013

    Article  PubMed  CAS  Google Scholar 

  33. Hubert P, Nguyen-Huu JJ, Boulanger B, Chapuzet E, Cohen N, Compagnon PA, Dewe W, Feinberg M, Laurentie M, Mercier N, Muzard G, Valat L, Rozet E (2007) Harmonization of strategies for the validation of quantitative analytical procedures. A SFSTP proposal—part III. J Pharm Biomed Anal 45(1):82–96. doi:10.1016/j.jpba.2007.06.032

    Article  PubMed  CAS  Google Scholar 

  34. Matuszewski BK, Constanzer ML, Chavez-Eng CM (2003) Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC–MS/MS. Anal Chem 75(13):3019–3030

    Article  PubMed  CAS  Google Scholar 

  35. Chauncey HH, Lionetti F, Winer RA, Lisanti VF (1954) Enzymes of human saliva. I. The determination, distribution, and origin of whole saliva enzymes. J Dent Res 33(3):321–334

    Article  PubMed  CAS  Google Scholar 

  36. Ghadge MS, Raste AS (2006) Place of salivary beta glucuronidase activity in head and neck cancers. Indian J Clin Biochem 21(1):196–198

    Article  PubMed  CAS  Google Scholar 

  37. Lamster IB, Kaufman E, Grbic JT, Winston LJ, Singer RE (2003) Beta-glucuronidase activity in saliva: relationship to clinical periodontal parameters. J Periodontol 74(3):353–359. doi:10.1902/jop.2003.74.3.353

    Google Scholar 

  38. Pil K, Verstraete A (2008) Current developments in drug testing in oral fluid. Ther Drug Monit 30(2):196–202. doi:10.1097/FTD.0b013e318167d563

    Article  PubMed  CAS  Google Scholar 

  39. Hazekamp A, Peltenburg A, Verpoorte R, Giroud C (2005) Chromatographic and spectroscopic data of cannabinoids from Cannabis sativa L. J Liq Chromatogr Relat Technol 28(15):2361–2382

    Article  CAS  Google Scholar 

  40. Poklis JL, Thompson CC, Long KA, Lichtman AH, Poklis A (2010) Disposition of cannabichromene, cannabidiol, and Delta(9)-tetrahydrocannabinol and its metabolites in mouse brain following marijuana inhalation determined by high-performance liquid chromatography–tandem mass spectrometry. J Anal Toxicol 34(8):516–520

    PubMed  CAS  Google Scholar 

  41. Barni-Comparini I, Ferri S, Centini F (1984) Cannabinoid level in the leaves as a tool for the early discrimination of cannabis chemiovariants. Forensic Sci Int 24(1):37–42

    Article  PubMed  CAS  Google Scholar 

  42. Skopp G, Potsch L (2002) Stability of 11-nor-delta(9)-carboxy-tetrahydrocannabinol glucuronide in plasma and urine assessed by liquid chromatography–tandem mass spectrometry. Clin Chem 48(2):301–306

    PubMed  CAS  Google Scholar 

  43. Humphrey SP, Williamson RT (2001) A review of saliva: normal composition, flow, and function. J Prosthet Dent 85(2):162–169. doi:10.1067/mpr.2001.113778

    Article  PubMed  CAS  Google Scholar 

  44. Skopp G, Potsch L, Mauden M, Richter B (2002) Partition coefficient, blood to plasma ratio, protein binding and short-term stability of 11-nor-Delta(9)-carboxy tetrahydrocannabinol glucuronide. Forensic Sci Int 126(1):17–23

    Article  PubMed  CAS  Google Scholar 

  45. Cone EJ, Huestis MA (2007) Interpretation of oral fluid tests for drugs of abuse. Ann N Y Acad Sci 1098:51–103. doi:10.1196/annals.1384.037

    Article  PubMed  CAS  Google Scholar 

  46. Smink BE, Hofman BJ, Dijkhuizen A, Lusthof KJ, de Gier JJ, Egberts AC, Uges DR (2008) The concentration of oxazepam and oxazepam glucuronide in oral fluid, blood and serum after controlled administration of 15 and 30 mg oxazepam. Br J Clin Pharmacol 66(4):556–560. doi:10.1111/j.1365-2125.2008.03252.x

    Article  PubMed  CAS  Google Scholar 

  47. Watanabe K, Oguri K, Yoshimura H (1979) Synthesis of delta 8-tetrahydrocannabinol glucuronide and sulfate, and their metabolic disposition in rats. Chem Pharm Bull 27(12):3009–3014

    Article  PubMed  CAS  Google Scholar 

  48. Scheidweiler KB, Desrosiers NA, Huestis MA (2012) Simultaneous quantification of free and glucuronidated cannabinoids in human urine by liquid chromatography tandem mass spectrometry. Clin Chim Acta Int J Clin Chem 413(23–24):1839–1847. doi:10.1016/j.cca.2012.06.034

    Article  CAS  Google Scholar 

  49. Wang RE, Tian L, Chang YH (2012) A homogeneous fluorescent sensor for human serum albumin. J Pharm Biomed Anal 63:165–169. doi:10.1016/j.jpba.2011.12.035

    Article  PubMed  CAS  Google Scholar 

  50. Fanali G, Cao Y, Ascenzi P, Trezza V, Rubino T, Parolaro D, Fasano M (2011) Binding of delta9-tetrahydrocannabinol and diazepam to human serum albumin. IUBMB Life 63(6):446–451. doi:10.1002/iub.466

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The authors thank the Swiss National Science Foundation (FNS_320030_127507/1) and the Faculty of Biology and Medicine (interdisciplinary grant) at the University of Lausanne for their financial support.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Christian Giroud.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fabritius, M., Staub, C., Mangin, P. et al. Analysis of cannabinoids in oral fluid by liquid chromatography–tandem mass spectrometry. Forensic Toxicol 31, 151–163 (2013). https://doi.org/10.1007/s11419-012-0168-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11419-012-0168-z

Keywords

Navigation